Cited by 66Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Development and validation of a cardiovascular risk prediction model for Japanese: the Hisayama study

Open access
Arima, Hisatomi, Yonemoto, Koji, Doi, Yasufumi, Ninomiya, Toshiharu, Hata, Jun, Tanizaki, Yumihiro, Fukuhara, Masayo, Matsumura, Kiyoshi +2 more·2009·Hypertension Research

Abstract

The objective of this paper is to develop a new risk prediction model of cardiovascular disease and to validate its performance in a general population of Japanese. The Hisayama study is a population-based prospective cohort study. A total of 2634 participants aged 40 years or older were followed up for 14 years for incident cardiovascular disease (stroke and coronary heart disease (myocardial infarction, coronary revascularization and sudden cardiac death)). We used data among a random two-thirds (the derivation cohort, n=1756) to develop a new risk prediction model that was then tested to compare observed and predicted outcomes in the remaining one-third (the validation cohort, n=878). A multivariable cardiovascular risk prediction model was developed that incorporated age, sex, systolic blood pressure, diabetes, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and smoking. We assessed the performance of the model for predicting individual cardiovascular event among the validation cohort. The risk prediction model demonstrated good discrimination (c-statistic=0.81; 95% confidence interval, 0.77 to 0.86) and calibration (Hosmer-Lemeshow chi(2)-statistic=6.46; P=0.60). A simple risk score sheet based on the cardiovascular risk prediction model was also presented. We developed and validated a new cardiovascular risk prediction model in a general population of Japanese. The risk prediction model would provide a useful guide to estimate absolute risk of cardiovascular disease and to treat individual risk factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/hr.2009.161

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arima, H., Yonemoto, K., Doi, Y., Ninomiya, T., Hata, J., Tanizaki, Y., Fukuhara, M., Matsumura, K., Iida, M., & Kiyohara, Y.
Affiliations
Kyushu University (JP)
Corresponding author
Arima, Hisatomi
Venue
Hypertension Research
Published
2009-09-18
Volume
32
Issue
12
Pages
1119-1122
ISSN
  • 0916-9636 (ISSN-L)
  • 1348-4214
OpenAlex
W1985719600
Cited by
66
References
25
Citations by year
2026: 6 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 1
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Hypertension Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (19590633, 18209024, 21590698)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
cardiovascular risk prediction models, Hisayama Study, Japanese population, stroke, coronary artery disease, myocardial infarction, coronary revascularization, sudden cardiac death, risk score, systolic blood pressure, diabetes mellitus, LDL cholesterol, HDL cholesterol, smoking, absolute risk estimation, model validation
MeSH terms
Adult, Aged, Cardiovascular Diseases, Female, Humans, Japan, Male, Middle Aged, Predictive Value of Tests, Prospective Studies, Risk Factors, Reproducibility of Results, Models, Statistical, Cohort Studies, Risk Assessment, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review